Adirondack Trust Co. Decreases Holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI)

Adirondack Trust Co. trimmed its holdings in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 2.8% in the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 5,245 shares of the exchange traded fund’s stock after selling 150 shares during the period. Adirondack Trust Co.’s holdings in SPDR S&P Biotech ETF were worth $400,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds and other institutional investors have also made changes to their positions in XBI. PNC Financial Services Group Inc. lifted its holdings in SPDR S&P Biotech ETF by 9.9% during the 1st quarter. PNC Financial Services Group Inc. now owns 23,283 shares of the exchange traded fund’s stock worth $2,107,000 after buying an additional 2,099 shares during the last quarter. Private Advisor Group LLC lifted its holdings in SPDR S&P Biotech ETF by 7.8% during the 1st quarter. Private Advisor Group LLC now owns 18,026 shares of the exchange traded fund’s stock worth $1,632,000 after buying an additional 1,304 shares during the last quarter. Advisory Alpha LLC purchased a new stake in SPDR S&P Biotech ETF during the 1st quarter worth about $109,000. Williams Jones & Associates LLC lifted its holdings in SPDR S&P Biotech ETF by 9.1% during the 1st quarter. Williams Jones & Associates LLC now owns 68,049 shares of the exchange traded fund’s stock worth $6,161,000 after buying an additional 5,678 shares during the last quarter. Finally, RPg Family Wealth Advisory LLC purchased a new stake in SPDR S&P Biotech ETF during the 1st quarter worth about $237,000.

NYSEARCA XBI traded down $0.33 during trading on Wednesday, reaching $74.72. 3,631,990 shares of the company’s stock were exchanged, compared to its average volume of 4,725,195. The company has a 50 day moving average price of $79.90 and a two-hundred day moving average price of $84.13. SPDR S&P Biotech ETF has a 1 year low of $64.38 and a 1 year high of $93.87.

The firm also recently declared a — dividend, which was paid on Wednesday, September 25th. Shareholders of record on Monday, September 23rd were issued a dividend of $0.0032 per share. This represents a yield of 0.1%. The ex-dividend date was Friday, September 20th.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.

Featured Story: Profit Margin

Institutional Ownership by Quarter for SPDR S&P Biotech ETF (NYSEARCA:XBI)

Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.